...
首页> 外文期刊>Radiation oncology >Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups
【24h】

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups

机译:独家影像指导的IMRT与根治性前列腺切除术以及术后IMRT对局部前列腺癌的治疗:基于风险组的配对分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background To investigate whether patients treated for a localized prostate cancer (PCa) require a radical prostatectomy followed by postoperative radiotherapy or exclusive radiotherapy, in the modern era of image guided IMRT. Methods 178 patients with PCa were referred for daily exclusive image guided IMRT (IG-IMRT) using an on-line 3D ultra-sound based system and 69 patients were referred for postoperative IMRT without image guidance after radical prostatectomy (RP + IMRT). Patients were matched in a 1:1 ratio according to their baseline risk group before any treatment. Late toxicity was scored using the CTV v3.0 scale. Biochemical failure was defined as a postoperative PSA?≤?0.1?ng/mL followed by 1 consecutive rising PSA for the postoperative group of patients and by the Phoenix definition (nadir + 2?ng/mL) for the group of patients treated with exclusive radiotherapy. Results A total of 98 patients were matched (49:49). From the start of any treatment, the median follow-up was 56.6?months (CI 95%?=?[49.6-61.2], range [18.2-115.1]). No patient had late gastrointestinal grade?≥?2 toxicity in the IG-IMRT group vs. 4% in the RP + IMRT group. Forty two percent of the patients in both groups had late grade?≥?2 genitourinary toxicity. The 5-year FFF rates in the IG-IMRT group and in the RP + IMRT groups were 93.1% [80.0-97.8] and 76.5% [58.3-87.5], respectively (p?=?0.031). Conclusions Patients with a localized PCa treated with IG-IMRT had better oncological outcome than patients treated with RP + IMRT. Further improvements in postoperative IMRT using image guidance and dose escalation are urgently needed.
机译:背景技术为了研究在影像引导的IMRT时代,接受局部前列腺癌(PCa)治疗的患者是否需要根治性前列腺切除术,然后进行术后放疗或独家放疗。方法采用在线3D超声检查系统对178例PCa患者进行每日独家影像引导IMRT(IG-IMRT),并在根治性前列腺切除术(RP + IMRT)后,对69例无影像指导的IMRT术后患者进行转诊。在进行任何治疗之前,根据基线风险组以1:1的比例对患者进行匹配。使用CTV v3.0量表对后期毒性进行评分。生化衰竭定义为术后组患者术后PSA≤≤0.1ng/ mL,然后连续1次PSA升高; Phoenix定义为排他性患者治疗组(nadir + 2ng / mL)放疗。结果共匹配98例患者(49:49)。从开始任何治疗开始,中位随访时间为56.6?个月(CI 95%?=?[49.6-61.2],范围[18.2-115.1])。 IG-IMRT组无胃肠道晚期毒性≥2级患者,而RP + IMRT组为4%。两组中有百分之四十二的患者有晚期≥≥2泌尿生殖系统毒性。 IG-IMRT组和RP + IMRT组的5年FFF率分别为93.1%[80.0-97.8]和76.5%[58.3-87.5](p?=?0.031)。结论IG-IMRT治疗局部PCa的患者的肿瘤学结局优于RP + IMRT治疗的患者。迫切需要使用图像指导和剂量递增进一步改善术后IMRT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号